Inhibitors of signal transduction: The alkylphosphocholines

被引：0

作者：

Hilgard, F ^{[1
]}

Klenner, T ^{[1
]}

Engel, J ^{[1
]}

机构：

[1] ASTA Med AG, Expt Canc Res, D-60001 Frankfurt, Germany

来源：

DRUG NEWS & PERSPECTIVES | 1999年 / 12卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The experimental antitumor activity of the alkylphosphocholines, a new class of signal transduction inhibitors, has been demonstrated repeatedly. The alkylphosphocholines have inhibitory activities on protein kinase C (PKC) and phospholipase C. The PKC pathway of signal transduction may be involved in cellular differentiation and in the induction of apoptosis. Moreover, PKC inhibition by miltefosine may affect tumor invasion and metastasis formation. Miltefosine may also interfere with immunological mechanisms. Finally, in addition to its antitumor activity, miltefosine also exerts substantial effects on a number of Leishmania strains. In brief, miltefosine and other alkylphosphocholines interact with signal transduction components of cellular functions such as differentiation, growth control, migration, tumor promotion and cell death. Due to these activities, this new class of pharmacophores has a great potential in the treatment of cancer and certain parasitic diseases. (C) 1999 Prous Science. All rights reserved.

引用

页码：69 / 72

页数：4

共 50 条

[41] Isolation, synthesis, and biological activities of signal transduction inhibitors [J].

Umezawa, K ;

Watanabe, T .

JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1996, 54 (12) :1067-1075

[42] Dissecting the VanRS signal transduction pathway with specific inhibitors [J].

Ulijasz, AT ;

Weisblum, B .

JOURNAL OF BACTERIOLOGY, 1999, 181 (02) :627-631

[43] Oncogene signal transduction inhibitors from Chinese medicinal plants [J].

Chang, CJ ;

Ashendel, CL ;

Chan, TCK ;

Geahlen, RL ;

McLaughlin, J ;

Waters, DJ .

PURE AND APPLIED CHEMISTRY, 1999, 71 (06) :1101-1104

[44] PROTEASE INHIBITORS DECREASE STIMULATORY SIGNAL TRANSDUCTION IN GRANULOCYTES AND LYMPHOCYTES [J].

TCHORZEWSKI, H ;

KANTORSKI, J ;

WACHOWSKA, E .

JOURNAL OF IMMUNOLOGY, 1993, 150 (08) :A56-A56

[45] ANGELMICINS, NEW INHIBITORS OF ONCOGENIC SRC SIGNAL-TRANSDUCTION [J].

UEHARA, Y ;

LI, PM ;

FUKAZAWA, H ;

MIZUNO, S ;

NIHEI, Y ;

NISHIO, M ;

HANADA, M ;

YAMAMOTO, C ;

FURUMAI, T ;

OKI, T .

JOURNAL OF ANTIBIOTICS, 1993, 46 (08) :1306-1308

[46] Inhibitors of platelet signal transduction as anti-aggregatory drugs [J].

Geiger, J .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (05) :865-890

[47] ETC inhibitors alter oncogenic KRAS signal transduction. [J].

Sharma, Kanika ;

Yi, Ming ;

Grandinetti, Giovanna ;

Chougule, Ashish B. ;

Liaw, Philip ;

Yanofsky, Stephen ;

Ungashe, Solomon ;

Thomas, Jeffery H. ;

Garland, William ;

Holderfield, Matthew .

MOLECULAR CANCER RESEARCH, 2020, 18 (05) :58-58

[48] Inhibitors of the ras signal transduction pathway as potential antitumour agents [J].

Perrin, D ;

Halazy, S ;

Hill, BT .

JOURNAL OF ENZYME INHIBITION, 1996, 11 (02) :77-95

[49] SIGNAL TRANSDUCTION INHIBITORS AS NOVEL ANTICANCER DRUGS - WHERE ARE WE [J].

WORKMAN, P .

ANNALS OF ONCOLOGY, 1992, 3 (07) :527-531

[50] Novel chemical genetic approaches to the discovery of signal transduction inhibitors [J].

Shokat, K ;

Velleca, M .

DRUG DISCOVERY TODAY, 2002, 7 (16) :872-879

← 1 2 3 4 5 →